Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...
A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...
Objective Recent advances in giant cell arteritis (GCA) management aim to reduce glucocorticoid (GC). We described changes in ...
Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...
The US has revised testosterone therapy labels, removing age-related safety warnings based on new clinical evidence, ...
A simple formula developed at VCU two decades ago has become a global standard for liver disease detection, helping millions ...
After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, applauds ...
Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...
A Malaysian patient has successfully undergone pulse field ablation (PFA) for persistent atrial fibrillation (AF) in Shanghai. The procedure, performed by internationally renowned cardiac ...
Please provide your email address to receive an email when new articles are posted on . A low-calorie, behavioral support intervention helped older participants with obesity and persistent atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results